Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

AIMS: Metformin is the most widely used oral anti‐diabetes agent and has considerable benefits over other therapies, yet 20–30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these side effects. The mechanism for gastrointestinal side...

Descripción completa

Detalles Bibliográficos
Autores principales: Dujic, T., Causevic, A., Bego, T., Malenica, M., Velija‐Asimi, Z., Pearson, E. R., Semiz, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064645/
https://www.ncbi.nlm.nih.gov/pubmed/26605869
http://dx.doi.org/10.1111/dme.13040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064645/
https://www.ncbi.nlm.nih.gov/pubmed/26605869
http://dx.doi.org/10.1111/dme.13040

Ejemplares similares